// COMPANY
Alentis Therapeutics
SECTOR BIOTECHMENTIONS 3LAST SEEN NOVEMBER 9, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
funding·PitchBook News·NOVEMBER 9, 2026
Source→02
funding·StrictlyVC·NOVEMBER 6, 2026
“raised a $90 million Series A round co-led by Sofinnova Partners and RA Capital.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.